GOG 92: Sedlis Criteria Study Last updated on Jun 10, 2024 Previous SIENDO: Oral Selinexor Maintenance After First-Line Chemotherapy in Advanced or Recurrent Endometrial Cancer Next Early Stage Cervical Cancer - 2